Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about AligosTherapeutics-2021-06-30
$83.6 Million
Image
Aligos Therapeutics
Follow-On Offering
Active Bookrunner
Read more
about ProtagonistTherapeuticsInc-2021-06-15
$132.0 Million
Image
Protagonist Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about PraxisPrecisionMedicines-2021-05-13
$104.9 Million
Image
Praxis Precision Medicines
Follow-On Offering
Active Bookrunner
Read more
about AclarisTherapeuticsInc-2021-06-09
$143.8 Million
Image
Aclaris Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about HeskaCorporation-2021-03-02
$175.0 Million
Image
Heska Corporation
Follow-On Offering
Active Bookrunner
Read more
about SolidBiosciencesInc-2021-03-18
$143.7 Million
Image
Solid Biosciences Inc.
Follow-On Offering
Active Bookrunner
Read more
about ESSAPharmaInc-2021-02-17
$149.9 Million
Image
ESSA Pharma Inc.
Follow-On Offering
Active Bookrunner
Read more
about NurixInc-2021-03-04
$160.4 Million
Image
Nurix Inc.
Follow-On Offering
Active Bookrunner
Read more
about TCR2Therapeutics-2021-01-19
$140.0 Million
Image
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
Read more
about CytomXTherapeuticsInc-2021-01-20
$114.9 Million
Image
CytomX Therapeutics Inc.
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 23
Next page
››
Subscribe to Active Bookrunner
